SG
Sarah Gheuens sold $914K of AGIO stock
Sarah Gheuens, Chief Medical Officer of Agios Pharmaceuticals, Inc. (AGIO), sold 30,000 shares of AGIO stock worth $914K, per an SEC Form 4 filed Aug 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 4, 2026, 2 days before it was made public.
AGIO has moved -0.0% since the trade date, from $31.60 to $31.59 (Nov 13, 2026 close).
- Traded
- Aug 4, 2026
- Disclosed
- Aug 6, 2026
- Filing delay
- 2 days
- Price since
- -0.0%
- Role
- Chief Medical Officer
- Source
- SEC Form 4